Skip to main content
. 2025 Mar 21;16:1500997. doi: 10.3389/fimmu.2025.1500997

Table 3.

Comorbidities and selected clinical laboratory results of male patients.

Control (Ctrl+C) High-erythrocyte fraction (HighE) Normal fraction of erythrocytes (NormE) p-value
Total N 30 8 7 NA
Age (years) Mean (SD) 45.4 (12.4) 45.4 (11.5) 44.4 (10.9) 0.9
BMI (kg/m2) Mean (SD) 28.0 (3.9) 30.2 (5.5) 23.7 (3.5) 0.02**
B -Hb Mean (SD) 149.5 (9.9) 155.8 (12.2) 144.9 (8.9) 0.2
P -K Mean (SD) 4 (0.2) 3.6 (0.4) 3.7 (0.2) 0.01*
SP -Ca-Ion Mean (SD) 1.19 (0.025) 1.22 (0.029) 1.23 (0.026) 0.02*
P -APTT Mean (SD) 27.6 (1.9) 31.4 (1.9) 29.7 (3.4) 0.03*
P -Fibr Mean (SD) 2.7 (0.5) 3.2 (0.2) 2.7 (0.6) 0.05*
Elevated P -CRP N (%) 1 (6.7) 0 (0) 0 (0) >.99
No of comorbidities Mean (SD) 0.27 (0.6) 1.5 (1.8) 1.6 (1.1) <.001*
Smoking, N (%) 3 (10) 1 (12.5) 0 (0) 0.9
Asthma N (%) 2 (6.7) 3 (37.5) 1 (14.3) 0.09*
Diabetes N (%) 0 (0) 2 (25) 1 (14.3) 0.04*
Sleep Apnea N (%) 2 (6.7) 2 (25) 2 (28.6) 0.1
Month 0 No of symptoms Mean (SD) 4.4 (4.3) 23 (4.5) 19.6 (6.9) <.001*

**Significant difference between Normal and High erythrocyte groups.

*Significant difference between PCC and control groups.